What a Management Consultant Costs
in Healthcare Providers

The short answer

You are not buying hours. You are buying a pyramid, and the shape of it decides the invoice more than the exposure on attributed lives does. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.

Fees appear as a single project total because the firm builds a team around the value-based contract review. A partner attends the opening meetings with the CFO or medical director, a manager directs the data pulls on cost per episode, and several analysts compile payer mix and panel size figures. The blended rate follows from the headcount needed to trace contribution per provider across the thirty-eight thousand attributed lives.

This structure shows why the people doing the daily work differ from those present at the sale, why the total grows with the weeks required to assemble episode data rather than with the complexity of the payer mix, and why stating the exact boundaries of the cost-per-episode question removes more cost than changing any rate.

The larger expense occurs inside the provider group. Medical directors and finance staff spend repeated hours supplying episode-level costs, confirming attributed lives lists, and attending reviews, often equaling the external fee across a twelve-week review of the thirty-eight thousand lives.

The real test is whether the fee is small relative to the capital tied to the value-based contract decision. When the contract covers thirty-eight thousand lives, clarifying contribution per provider offsets downside risk; when the question is narrower, internal modeling on panel size produces the same inputs faster.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ The proposal arrives as one total without showing how many analysts will be assigned to cost-per-episode extraction from the attributed lives.
✓ The scope is fixed before anyone has written the single sentence stating which payer mix or panel size question is being answered.
✓ Internal time for pulling episode data and running steering sessions has never been added up against the thirty-eight thousand lives.

The move that usually makes it worse. Negotiating the blended rate instead of removing a workstream on payer mix, which trims only a fraction of a fee set by the number of attributed lives under review.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and the proposal quotes a total and will not break out the team composition. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

Why are the big firms so much more expensive?

Partly brand and partly the pyramid, but mostly risk transfer. A board that has bought a recommendation from a well-known firm has a defensible position if it goes wrong, and that defensibility is a real product with a real price. If nobody needs to be protected — an owner-managed business deciding its own capital — you are paying for insurance you will never claim on.

Is an independent consultant a cheaper equivalent?

Cheaper, yes; equivalent, sometimes. An experienced independent at £1,000 a day often produces better judgement than a junior team at three times the blended cost, because judgement is what you are short of. What they cannot supply is throughput — one person cannot interview forty people in three weeks. Match it to whether your constraint is thinking or hands.

How do I compare a software subscription to a consulting fee honestly?

Compare like for like: the software replaces the analysis, not the delivery, the relationship, or the accountability. A fair comparison is a subscription against the diagnostic phase of an engagement — typically £75k–£250k — and not against the whole programme. Where the diagnosis is genuinely all you needed, the gap is very large. Where it is not, the subscription does not close it.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.